SF3B1 and chronic myelomonocytic leukemia: Regarding other clinical features, we observed that when RS are predominant and regardless of the presence of SF3B1 mutation, CMML and MDS patients share the main clinical characteristics, supporting the hypothesis that RS play a greater role than the monocyte count in determining the phenotype, which is closer to MDS than CMML.